gemcitabine/nab-paclitaxel | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

11,193 results for “gemcitabine/nab-paclitaxel”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer

2 participants · First posted Sep 16, 2014

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

183 participants · First posted Apr 10, 2025

Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer

40 participants · First posted Dec 17, 2014

Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer

25 participants · First posted Jul 26, 2018

Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer

12 participants · First posted Nov 29, 2016

Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma

180 participants · First posted Aug 25, 2016

Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer

15 participants · First posted Jun 30, 2014

Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal Cytology

21 participants · First posted Oct 11, 2018

Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer

50 participants · First posted Mar 23, 2016

The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer

40 participants · First posted Jan 17, 2018

Page 1 of 932